Literature DB >> 12971963

Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats.

Peter Stärkel1, Christine Sempoux, Isabelle Leclercq, Michel Herin, C Deby, Jean-Pierre Desager, Yves Horsmans.   

Abstract

BACKGROUND/AIMS: Pathogenesis of non-alcoholic steatohepatitis (NASH) remains poorly understood. Cytochrome P450 2E1 (CYP 2E1), cytokines, oxidative stress and activation of hepatic stellate cells seem to play a role in this process. The aim was to determine the potential implication of these factors in the progression from uncomplicated steatosis to steatohepatitis with progressive fibrosis.
METHODS: Animals were fed a standard diet, a 5% orotic acid-diet (OA) developing hepatic steatosis, or the methionine-choline deficient (MCD) diet inducing steatohepatitis for 2 and 6 weeks. Lipid peroxidation, CYP 2E1 expression and activity, expression of UCP-2, interleukin (IL)-6, transforming growth factor (TGF)beta1, KLF6 mRNAs, and activation of hepatic stellate cells were examined by gas chromatography, high-performance liquid chromatography, Western blotting, quantitative polymerase chain reaction and immunohistochemistry.
RESULTS: Lipid peroxidation increased in the MCD model whereas only minor changes occurred in the OA model. KLF6 and TGFbeta1 mRNAs were selectively up-regulated in MCD animals. Stellate cell activation, inflammation and collagen deposition only occurred in the MCD group. CYP 2E1 expression and activity increased in the OA group while both decreased in MCD animals. UCP-2 and IL-6 mRNA increased in both groups.
CONCLUSIONS: In the context of steatosis, lipid peroxidation is associated with inflammation and stellate cell activation with concomitant increase in TGFbeta1 production, possibly through up-regulation of KLF6.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12971963     DOI: 10.1016/s0168-8278(03)00360-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  51 in total

1.  Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease.

Authors:  Bernd Schnabl; Barbara Czech; Daniela Valletta; Thomas S Weiss; Georgi Kirovski; Claus Hellerbrand
Journal:  Int J Clin Exp Pathol       Date:  2011-09-22

2.  Smad7 dependent expression signature highlights BMP2 and HK2 signaling in HSC transdifferentiation.

Authors:  Bernd Denecke; Lucia Wickert; Yan Liu; Loredana Ciuclan; Steven Dooley; Nadja M Meindl-Beinker
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

3.  Experimental models of non-alcoholic fatty liver disease in rats.

Authors:  Otto Kucera; Zuzana Cervinkova
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 4.  SP and KLF Transcription Factors in Digestive Physiology and Diseases.

Authors:  Chang-Kyung Kim; Ping He; Agnieszka B Bialkowska; Vincent W Yang
Journal:  Gastroenterology       Date:  2017-03-30       Impact factor: 22.682

Review 5.  Role of cytokines and chemokines in non-alcoholic fatty liver disease.

Authors:  Vincent Braunersreuther; Giorgio Luciano Viviani; François Mach; Fabrizio Montecucco
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

6.  Research Resource: A Reference Transcriptome for Constitutive Androstane Receptor and Pregnane X Receptor Xenobiotic Signaling.

Authors:  Scott A Ochsner; Anna Tsimelzon; Jianrong Dong; Cristian Coarfa; Neil J McKenna
Journal:  Mol Endocrinol       Date:  2016-07-13

Review 7.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

8.  MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis.

Authors:  Wei-Chih Tsai; Sheng-Da Hsu; Chu-Sui Hsu; Tsung-Ching Lai; Shu-Jen Chen; Roger Shen; Yi Huang; Hua-Chien Chen; Chien-Hsin Lee; Ting-Fen Tsai; Ming-Ta Hsu; Jaw-Ching Wu; Hsien-Da Huang; Ming-Shi Shiao; Michael Hsiao; Ann-Ping Tsou
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

Review 9.  Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management.

Authors:  Vishnubhotla Venkata Ravi Kanth; Mitnala Sasikala; Mithun Sharma; Padaki Nagaraja Rao; Duvvuru Nageshwar Reddy
Journal:  World J Hepatol       Date:  2016-07-18

10.  Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats.

Authors:  I A Leclercq; C Sempoux; P Stärkel; Y Horsmans
Journal:  Gut       Date:  2006-02-16       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.